BoneSupport said today that the 1st patient has been enrolled in the pivotal investigational device exemption trial for its injectable antibiotic-eluting bone graft substitute. The company’s Fortify trial plans to evaluate Cerament G’s ability to improve the traditional management of patients with open factures of the tibial diaphysis. The trial is slated to enroll up […]
Surgical
Study: Rivanna’s anesthesia placement device boosts accuracy, efficacy
Rivanna Medical touted data from 3 trials today showing that its Accuro automatic spinal navigation system boosts the accuracy of epidural and spinal anesthesia placement compared to traditional techniques, even for residents-in-training. Accuro is a pocket-sized ultrasound system that automatically detects spinal midline, epidural depth and trajectory. One trial at the University of Virginia Medical […]
Ethicon touts new anti-infection suture guidelines
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon touted updated anti-infection suture guidelines from the Centers for Disease Control and Prevention, which recommend that healthcare professionals “consider the use of triclosan-coated sutures for the prevention of SSI [surgical site infection].” Ethicon Plus Sutures are the only globally available sutures coated with triclosan that stop bacteria commonly associated with […]
New medicines could eliminate uterine fibroid surgeries
Decisions Resources Group, a healthcare research and data company, suggests that the launch of new medicines could be a long-term management alternative to uterine fibroids surgeries over the next 10 years. Novel selective progesterone receptor modulators (SPRMs) like Allergan/Gedeon Richter’s ulipristal, Bayer’s vilaprisan and Repros’s Proellex – and gonadotropin-releasing hormone (Gn-RH) antagonists like AbbVie’s elagolix, […]
Kala touts Phase III data for nanoparticle ophthalmic suspension
Kala Pharmaceuticals touted data today from a Phase III trial of its nanoparticle formulation of loteprednol etabonate as a treatment for inflammation and pain in cataract surgery patients. The KPI-121 1% suspension met both primary efficacy endpoints and secondary endpoints and was well tolerated by the trial’s participants. The Waltham, Mass.-based company’s KPI-121 uses Kala’s mucus-penetrating […]
AcelRx touts data from Dsuvia pain relief trials
AcelRx Pharmaceuticals (NSDQ:ACRX) touted efficacy and safety data today for its pain reliever, Dsuvia. The company’s lead drug candidate is composed of 30 sufentanil tablets delivered sublingually using a disposable, pre-filled single-dose applicator. Dsuvia is investigational and not approved in any country. The 4 late-phase studies enrolled 480 patients total. In 2 randomized studies, enrolled patients underwent bunionectomy […]
Philips sees image-guided therapy transforming healthcare: Here’s how
Officials at medtech giant Royal Philips see image-guided therapy as key when it comes to health practitioners providing care that is both efficient and effective. The Dutch multinational’s work in the field provides a great example of how the ever-growing need for cost-effective healthcare around the world is driving the strategies of medical device companies. […]
NuTech Medical acquired by Organogenesis
Organogenesis said today that it acquired NuTech Medical for an undisclosed price. The combined company plans to feature a portfolio of wound care products and surgical biologics. Birmingham, Alabama-based NuTech Medical will keep it’s non-biologics product line as a separate company called NuTech Spine. “This is an important transaction for the regenerative medicine field. It unites […]
Integra, Dr. Reddy’s ink deal for DuraGen in India
Integra LifeSciences (NSDQ:IART) and Dr. Reddy’s Laboratories (NYSE:RDY) inked an exclusive distribution agreement for the DuraGen Plus and suturable DuraGen Dural Regeneration Matrices in India. According to the deal, Dr. Reddy’s will market and distribute the medical devices throughout India. The DuraGen Plus Dural Regeneration Matrix is indicated as a dural susbtitute for the repair of […]
Study: Vision loss treatment linked to higher risk of glaucoma surgery
Researchers from the University of British Columbia found that patients with age-related macular degeneration who had at least 7 eye injections per year had a heightened risk of having glaucoma surgery. The team’s findings were published this week in JAMA Ophthalmology. Patients with wet age-related macular degeneration and diabeteic macular edema, common causes of vision loss, are […]
